Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Medicine / 醫學系
  4. Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study
 
  • Details

Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study

Journal
American Journal of Hematology
Journal Volume
89
Journal Issue
7
Pages
751-756
Date Issued
2014
Author(s)
Kim K.
Lee J.H.
Kim J.S.
Min C.K.
Yoon S.S.
Shimizu K.
Chou T.
Kosugi H.
Suzuki K.
Chen W.
Hou J.
Lu J.
Huang X.-J.
SHANG-YI HUANG  
Chng W.J.
Tan D.
Teoh G.
Chim C.S.
Nawarawong W.
Siritanaratkul N.
Durie B.G.
DOI
10.1002/ajh.23731
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902775045&doi=10.1002%2fajh.23731&partnerID=40&md5=7bd5ee271d0c66ea1bf37ef2b3df9bcf
https://scholars.lib.ntu.edu.tw/handle/123456789/540476
Abstract
The incidence of multiple myeloma (MM) is known to be variable according to ethnicity. However, the differences in clinical characteristics between ethnic groups are not well-defined. In Asian countries, although the incidence of MM has been lower than that of Western countries, there is growing evidence that MM is increasing rapidly. The Asian Myeloma Network decided to initiate the first multinational project to describe the clinical characteristics of MM and the clinical practices in Asia. Data were retrospectively collected from 23 centers in 7 countries and regions. The clinical characteristics at diagnosis, survival rates and initial treatment of 3,405 symptomatic MM patients were described. Median age was 62 years (range, 19-106), with 55.6% of being male. Median overall survival (OS) was 47 months (95% CI 44.0-50.0). Stem cell transplantation was performed in 666 patients who showed better survival rates (79 vs. 41 months, P<0.001). The first-line treatments of 2,970 patients were analyzed. The overall response rate was 71% including very good partial response or better in 31% of the 2,660 patients those were able to be evaluated. New drugs including bortezomib, thalidomide, and lenalidomide were used in 36% of 2,970 patients and affected OS when used as a first-line treatment. Am. J. Hematol. 89:751-756, 2014. ? 2014 Wiley Periodicals, Inc.
SDGs

[SDGs]SDG3

Other Subjects
beta 2 microglobulin; bortezomib; calcium; creatinine; hemoglobin; immunoglobulin A; immunoglobulin D; immunoglobulin G; immunoglobulin heavy chain; lenalidomide; serum albumin; thalidomide; adult; age distribution; aged; article; Asia; Asian; autologous stem cell transplantation; bone lesion; bone marrow cell; calcium blood level; cancer survival; China; clinical feature; clinical practice; creatinine blood level; diploidy; female; genetic polymorphism; hemoglobin blood level; Hong Kong; human; Japan; Korea; major clinical study; male; multicenter study; multiple myeloma; overall survival; plasma cell; plasmacytoma; priority journal; retrospective study; Singapore; survival rate; Taiwan; Thailand; thrombocyte count; treatment response; very elderly; Adult; Aged; Aged, 80 and over; Asia; Female; Humans; Incidence; Male; Middle Aged; Multiple Myeloma; Prognosis; Retrospective Studies; Survival Analysis; Young Adult
Publisher
Wiley-Liss Inc.
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science